SABBY 13G ABIO 6.01.20

Company

Oruka Therapeutics, Inc.

Filed

June 1, 2020

Accession Number

0001535610-20-000096

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →